Loss of Response
This IBD clinical care pathway is a guideline for healthcare professionals to achieve and maintain remission with advanced therapy, especially for adult IBD patients who are on newer biologics and small molecules.
Use the Pathway
Download the PDF
This Clinical Care Pathway was updated from the previous December 2024 version.
Disclaimer
Clinical care pathways are not a substitute for the personalized judgement and care of a trained healthcare professional.
Dr. Jesse Siffledeen (University of Alberta & Covenant Health/Grey Nuns Hospital Edmonton) and Dr. Vivian Huang (University of Toronto & Mount Sinai Hospital) are the leads for this clinical care pathway, including regular review and maintenance.